Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems

QR Code

Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems

Objectives The frontline drug doxorubicin has been used for treating cancer for over 30 years. While providing a cure in select cases, doxorubicin causes toxicity to most major organs, especially life-threatening cardiotoxicity, which forces the treatment to become dose-limiting. Key findings Doxoru...

Full description

Bibliographic Details
Main Authors:	Tacar, O., Sriamornsak, P., Dass, Crispin
Format:	Journal Article
Published:	John Wiley & Sons Ltd. 2013
Online Access:	http://hdl.handle.net/20.500.11937/19817

Similar Items

Thiolated pectin–doxorubicin conjugates: Synthesis, characterization and anticancer activity studies
by: Cheewatanakornkool, K., et al.
Published: (2017)

Novel pH-responsive dextrin nanogels for doxorubicin delivery to cancer cells with reduced cytotoxicity to cardiomyocytes and stem cells
by: Manchun, S., et al.
Published: (2014)

Doxorubicin: The dogma and the bone
by: Wong, J., et al.
Published: (2016)

Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?
by: Tacar, O., et al.
Published: (2013)

Biodegradable drug delivery systems for cancer therapy
by: Wong, T., et al.
Published: (2017)

Doxorubicin action on mitochondria: relevance to osteosarcoma therapy?
by: Armstrong, J., et al.
Published: (2015)

Stability of freeze-dried pH-responsive dextrin nanogels containing doxorubicin
by: Manchun, S., et al.
Published: (2016)

Anti-Tumour Effect of a Chitosan Delivery System for Doxorubicin
by: Tan, M., et al.
Published: (2010)

Doxorubicin, mesenchymal stem cell toxicity and antitumour activity: implications for clinical use
by: Baxter-Holland, M., et al.
Published: (2018)

Enhanced anti-tumor effect of pH-responsive dextrin nanogels delivering doxorubicin on colorectal cancer
by: Manchun, S., et al.
Published: (2015)

Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: Comparison with osteosarcoma cells
by: Tacar, O., et al.
Published: (2015)

Redox-responsive microbeads containing thiolated pectin-doxorubicin conjugate inhibit tumor growth and metastasis: An in vitro and in vivo study
by: Cheewatanakornkool, K., et al.
Published: (2018)

Characterization and in vitro release studies of oral microbeads containing thiolated pectin-doxorubicin conjugates for colorectal cancer treatment
by: Cheewatanakornkool, K., et al.
Published: (2017)

Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis
by: Friedhuber, A., et al.
Published: (2015)

Drug delivery in cancer using liposomes
by: Dass, Crispin
Published: (2008)

Treatment of lung cancer using nanoparticle drug delivery systems
by: Chandolu, V., et al.
Published: (2013)

Delivery of nanoparticulate drug delivery systems via the intravenous route for cancer gene therapy
by: Hallaj-Nezhadi, S., et al.
Published: (2010)

Recent update on nanoemulgel as topical drug delivery system
by: Choudhury, Hira, et al.
Published: (2017)

Doxorubicin-loaded magnetic gold nanoshells for a combination therapy of hyperthermia and drug delivery
by: Mohammad, Faruq, et al.
Published: (2014)

Doxorubicin-Conjugated Mesoporous Magnetic Colloidal Nanocrystal Clusters Stabilized by Polysaccharide as a Smart Anticancer Drug Vehicle
by: Li, D., et al.
Published: (2012)

Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model
by: Tan, M., et al.
Published: (2013)

Nose to brain drug delivery: a recent update
by: Chatterjee, Bappaditya
Published: (2017)

Pigment epithelium-derived factor as an anticancer drug and new treatment methods following the discovery of its receptors: a patent perspective
by: Manalo, K., et al.
Published: (2011)

Targeted therapy for cancer using pH-responsive nanocarrier systems
by: Manchun, S., et al.
Published: (2012)

Synergistic anticancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL) and doxorubicin using micellar polymer nanoparticles
by: Lee, A., et al.
Published: (2012)

Designing nanoemulsion templates for fabrication of dextrin nanoparticles via emulsion cross-linking technique
by: Manchun, S., et al.
Published: (2014)

Bone drug targets
by: Dass, Crispin
Published: (2018)

PEGylated Oleic Acid-Lecithin Liposomes (POLL) for anticancer drug delivery
by: Vicit Rizal Eh Suk,, et al.
Published: (2020)

Graphene oxide-based hydrogels as a nanocarrier for anticancer drug delivery
by: Ghawanmeh, Abdullah A., et al.
Published: (2019)

Weak bones in diabetes mellitus - an update on pharmaceutical treatment options
by: Lin, D., et al.
Published: (2017)

Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus
by: Wong, Chun Yuen, et al.
Published: (2018)

Gastro-retentive drug delivery systems and their in vivo success: A recent update
by: Mandal, Uttam Kumar, et al.
Published: (2016)

Development of a polysaccharide-based hydrogel drug delivery system (DDS): An update
by: Pushpamalar, Janarthanan, et al.
Published: (2021)

Transdermal drug delivery system through polymeric microneedle: A recent update
by: Azmana, Motia, et al.
Published: (2020)

Functionalized ionic-liquid templated mesoporous silica nanoparticles for anticancer drug delivery system
by: Zaharudin, Nurul Syahira
Published: (2018)

Autophagy and cancer: taking the ‘toxic’ out of cytotoxics
by: Giuliani, C., et al.
Published: (2013)

In vitro delivery and controlled release of doxorubicin for targeting osteosarcoma bone cancer
by: Kamba, Shafiu Abdullahi, et al.
Published: (2013)

Combine drug delivery of Thymoquinone-doxorubicin by cockles shell derived pH-sensitive Aragonite CaCO3 nanoparticles
by: Ibiyeye, Kehinde M., et al.
Published: (2020)

The molecular basis of atypicality in antipsychotic drug action
by: Lockington, Hannah J.
Published: (2025)

Microencapsulation of drug into biodegradable polymer as a novel drug delivery system
by: Mohamed, Farahidah, et al.
Published: (2011)